FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000950725> ?p ?o ?g. }

• W2000950725 endingPage "526" @default.
• W2000950725 startingPage "518" @default.
• W2000950725 abstract "Cryoglobulinemic vasculitis (CV) involving small- and medium-sized vessels is very frequently associated with hepatitis C virus and may be responsible for multiple organ involvement and skin ulcers (SU). Skin ulcers are often non-healing cutaneous lesions, possibly complicated by local infection and gangrene; they may severely affect the patients׳ quality of life and the overall prognosis. Therefore, the treatment of cryoglobulinemic SU is particularly challenging in the clinical practice. The present work evaluated the prevalence and correlations of cryoglobulinemic SU with other clinico-epidemiological features of CV; moreover, our long-term experience with the management strategies of these cutaneous lesions was compared with the world literature on this topic. The study included 126 CV patients (24 male and 102 female, aged 69 ± 11.2 SD years, disease duration 7 ± 6.9 SD years), followed at our Rheumatology Unit during the past decade. All patients were carefully evaluated regarding the entire cryoglobulinemic syndrome with particular concern for clinical characteristics and treatment of SU. Among 126 CV patients, 36 individuals (29%) experienced at least one episode of SU, more commonly localized at the lower limbs. Patients with complicating SU showed significantly higher percentage of purpuric manifestations (p < 0.01) and liver (p < 0.001), peripheral nerve (p < 0.02), and/or thyroid involvement (p = 0.019). Therapeutic approach to SU included both systemic (immunosuppressors, corticosteroids, and/or plasma exchange) and local treatments. Local treatments consisted of sharp or surgical debridement as well as interactive dressing according to the condition of wound bed, perilesional skin, and the possible presence of infection, detected in 29 of 36 (81%) individuals in our Rheumatology unit. All patients underwent analgesic treatment for SU-related background pain as well as procedural pain, which was critical for an effective local SU management. The large majority of patients with SU healed at a variable time interval according to the severity of the single lesion; only five patients with very severe, non-healing SU needed amputation. The updated review of the literature revealed the presence of SU in around a quarter of CV patients. Among systemic treatments, the anti-CD20 monoclonal antibody rituximab represents one of the most effective and frequently employed therapies; however, the available data focusing on local therapeutic approach are generally limited to anecdotal observations. Overall, the treatment of cryoglobulinemic SU should be tailored to the single patient׳s conditions using combined systemic and local treatments; lesional sharp debridement and interactive dressing as well as procedural pain management were decisive, particularly for more severe, non-healing cutaneous lesions." @default.
• W2000950725 created "2016-06-24" @default.
• W2000950725 creator A5014786793 @default.
• W2000950725 creator A5039319216 @default.
• W2000950725 creator A5051113191 @default.
• W2000950725 creator A5078370156 @default.
• W2000950725 creator A5085551138 @default.
• W2000950725 date "2015-04-01" @default.
• W2000950725 modified "2023-10-03" @default.
• W2000950725 title "Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature" @default.
• W2000950725 cites W16039427 @default.
• W2000950725 cites W1964985725 @default.
• W2000950725 cites W1965057295 @default.
• W2000950725 cites W1967429097 @default.
• W2000950725 cites W1975848602 @default.
• W2000950725 cites W1982445083 @default.
• W2000950725 cites W1982644308 @default.
• W2000950725 cites W1996962274 @default.
• W2000950725 cites W2002407449 @default.
• W2000950725 cites W2003036666 @default.
• W2000950725 cites W2006031438 @default.
• W2000950725 cites W2014966451 @default.
• W2000950725 cites W2018846108 @default.
• W2000950725 cites W2019376718 @default.
• W2000950725 cites W2019438317 @default.
• W2000950725 cites W2019985783 @default.
• W2000950725 cites W2024883447 @default.
• W2000950725 cites W2027155525 @default.
• W2000950725 cites W2028453745 @default.
• W2000950725 cites W2035038761 @default.
• W2000950725 cites W2040965564 @default.
• W2000950725 cites W2043914719 @default.
• W2000950725 cites W2044628656 @default.
• W2000950725 cites W2044713055 @default.
• W2000950725 cites W2044784043 @default.
• W2000950725 cites W2046900942 @default.
• W2000950725 cites W2051230364 @default.
• W2000950725 cites W2052536232 @default.
• W2000950725 cites W2053668889 @default.
• W2000950725 cites W2060312406 @default.
• W2000950725 cites W2061389251 @default.
• W2000950725 cites W2063148436 @default.
• W2000950725 cites W2063760041 @default.
• W2000950725 cites W2064967094 @default.
• W2000950725 cites W2069007901 @default.
• W2000950725 cites W2072771481 @default.
• W2000950725 cites W2076403369 @default.
• W2000950725 cites W2080006817 @default.
• W2000950725 cites W2089281661 @default.
• W2000950725 cites W2090887217 @default.
• W2000950725 cites W2093097715 @default.
• W2000950725 cites W2093820793 @default.
• W2000950725 cites W2101299701 @default.
• W2000950725 cites W2109380870 @default.
• W2000950725 cites W2112234313 @default.
• W2000950725 cites W2123222332 @default.
• W2000950725 cites W2136183837 @default.
• W2000950725 cites W2138649904 @default.
• W2000950725 cites W2138844596 @default.
• W2000950725 cites W2146137484 @default.
• W2000950725 cites W2158324098 @default.
• W2000950725 cites W2158977173 @default.
• W2000950725 cites W2163712689 @default.
• W2000950725 cites W2164059182 @default.
• W2000950725 cites W2165542457 @default.
• W2000950725 cites W2166590867 @default.
• W2000950725 cites W2168495604 @default.
• W2000950725 cites W2168589393 @default.
• W2000950725 cites W2432437627 @default.
• W2000950725 cites W4210979728 @default.
• W2000950725 doi "https://doi.org/10.1016/j.semarthrit.2014.10.004" @default.
• W2000950725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25547031" @default.
• W2000950725 hasPublicationYear "2015" @default.
• W2000950725 type Work @default.
• W2000950725 sameAs 2000950725 @default.
• W2000950725 citedByCount "18" @default.
• W2000950725 countsByYear W20009507252015 @default.
• W2000950725 countsByYear W20009507252016 @default.
• W2000950725 countsByYear W20009507252017 @default.
• W2000950725 countsByYear W20009507252018 @default.
• W2000950725 countsByYear W20009507252019 @default.
• W2000950725 countsByYear W20009507252020 @default.
• W2000950725 countsByYear W20009507252021 @default.
• W2000950725 countsByYear W20009507252022 @default.
• W2000950725 crossrefType "journal-article" @default.
• W2000950725 hasAuthorship W2000950725A5014786793 @default.
• W2000950725 hasAuthorship W2000950725A5039319216 @default.
• W2000950725 hasAuthorship W2000950725A5051113191 @default.
• W2000950725 hasAuthorship W2000950725A5078370156 @default.
• W2000950725 hasAuthorship W2000950725A5085551138 @default.
• W2000950725 hasBestOaLocation W20009507252 @default.
• W2000950725 hasConcept C107130276 @default.
• W2000950725 hasConcept C126322002 @default.
• W2000950725 hasConcept C141071460 @default.
• W2000950725 hasConcept C16005928 @default.
• W2000950725 hasConcept C198451711 @default.
• W2000950725 hasConcept C203014093 @default.
• W2000950725 hasConcept C2522874641 @default.

• next